The expanding roles of the ghrelin-gene derived peptide obestatin in health and disease

Molecular and Cellular Endocrinology

Volumn 340, Issue 1, 2011, Pages 111-117

  Seim, Inge ^a   Walpole, Carina ^a   Amorim, Laura ^a   Josh, Peter ^a,b   Herington, Adrian ^a   Chopin, Lisa ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b CSIRO   (Australia)

Author keywords

Disease; Ghrelin; Obestatin; Peptide hormone; Physiology

Indexed keywords

GLUCOSE; INSULIN; OBESTATIN;

ADIPOSE TISSUE; APOPTOSIS; BLOOD PRESSURE REGULATION; BODY WEIGHT; CANCER GROWTH; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; ENERGY METABOLISM; FOOD INTAKE; GENE EXPRESSION; GLUCOSE METABOLISM; HOMEOSTASIS; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; INSULIN RELEASE; KIDNEY; NONHUMAN; OBESITY; OVARY CANCER; PANCREAS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; STOMACH MOTILITY;

ANIMALS; DISEASE; GHRELIN; HEALTH; HUMANS; MODELS, BIOLOGICAL;

EID: 79958170443     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.03.018     Document Type: Review

References (103)

1. Alexandridis E., Zisimopoulos A., Liratzopoulos N., Katsos I., Manolas K., Kouklakis G. Obestatin/ghrelin ratio: a new activity index in inflammatory bowel diseases. Inflamm. Bowel Dis. 2009, 15:1557-1561.
2. Alloatti G., Arnoletti E., Bassino E., Penna C., Perrelli M.G., Ghe C., Muccioli G. Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:H470-H481.
3. Alvarez C.J., Lodeiro M., Theodoropoulou M., Camina J.P., Casanueva F.F., Pazos Y. Obestatin stimulates Akt signalling in gastric cancer cells through beta-arrestin-mediated epidermal growth factor receptor transactivation. Endocr. Relat. Cancer 2009, 16:599-611.
4. Anderwald-Stadler M., Krebs M., Promintzer M., Mandl M., Bischof M.G., Nowotny P., Kastenbauer T., Luger A., Prager R., Anderwald C. Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E1393-E1398.
5. Ataka K., Inui A., Asakawa A., Kato I., Fujimiya M. Obestatin inhibits motor activity in the antrum and duodenum in the fed state of conscious rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G1210-G1218.
6. Aygen B., Dogukan A., Dursun F.E., Aydin S., Kilic N., Sahpaz F., Celiker H. Ghrelin and obestatin levels in end-stage renal disease. J. Int. Med. Res. 2009, 37:757-765.
7. Bang A.S., Soule S.G., Yandle T.G., Richards A.M., Pemberton C.J. Characterisation of proghrelin peptides in mammalian tissue and plasma. J. Endocrinol. 2007, 192:313-323.
8. Bassil A.K., Haglund Y., Brown J., Rudholm T., Hellstrom P.M., Naslund E., Lee K., Sanger G.J. Little or no ability of obestatin to interact with ghrelin or modify motility in the rat gastrointestinal tract. Br. J. Pharmacol. 2007, 150:58-64.
9. Bresciani E., Rapetti D., Dona F., Bulgarelli I., Tamiazzo L., Locatelli V., Torsello A. Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat. J. Endocrinol. Invest. 2006, 29:RC16-RC18.
10. Brunetti L., Di Nisio C., Recinella L., Orlando G., Ferrante C., Chiavaroli A., Leone S., Di Michele P., Shohreh R., Vacca M. Obestatin inhibits dopamine release in rat hypothalamus. Eur. J. Pharmacol. 2010, 641:142-147.
11. Brunetti L., Leone S., Orlando G., Recinella L., Ferrante C., Chiavaroli A., Di Nisio C., Di Michele P., Vacca M. Effects of obestatin on feeding and body weight after standard or cafeteria diet in the rat. Peptides 2009, 30:1323-1327.
12. Buscher A.K., Buscher R., Hauffa B.P., Hoyer P.F. Alterations in appetite-regulating hormones influence protein-energy wasting in pediatric patients with chronic kidney disease. Pediatr. Nephrol. 2010, 25:2295-2301.
13. Camina J.P., Campos J.F., Caminos J.E., Dieguez C., Casanueva F.F. Obestatin-mediated proliferation of human retinal pigment epithelial cells: regulatory mechanisms. J. Cell. Physiol. 2007, 211:1-9.
14. Caminos J.E., Gualillo O., Lago F., Otero M., Blanco M., Gallego R., Garcia-Caballero T., Goldring M.B., Casanueva F.F., Gomez-Reino J.J., Dieguez C. The endogenous growth hormone secretagogue (ghrelin) is synthesized and secreted by chondrocytes. Endocrinology 2005, 146:1285-1292.
15. Carlini V.P., Schioth H.B., Debarioglio S.R. Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem. Biophys. Res. Commun. 2007, 352:907-912.
16. Ceranowicz P., Warzecha Z., Dembinski A., Cieszkowski J., Dembinski M., Sendur R., Kusnierz-Cabala B., Tomaszewska R., Kuwahara A., Kato I. Pretreatment with obestatin inhibits the development of cerulein-induced pancreatitis. J. Physiol. Pharmacol. 2009, 60:95-101.
17. Chartrel N., Alvear-Perez R., Leprince J., Iturrioz X., Reaux-Le Goazigo A., Audinot V., Chomarat P., Coge F., Nosjean O., Rodriguez M., Galizzi J.P., Boutin J.A., Vaudry H., Llorens-Cortes C. Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake" Science 2007, 315/766:766. (author reply).
18. Chen C.Y., Chien E.J., Chang F.Y., Lu C.L., Luo J.C., Lee S.D. Impacts of peripheral obestatin on colonic motility and secretion in conscious fed rats. Peptides 2008, 29:1603-1608.
19. Chen C.Y., Doong M.L., Li C.P., Liaw W.J., Lee H.F., Chang F.Y., Lin H.C., Lee S.D. A novel simultaneous measurement method to assess the influence of intracerebroventricular obestatin on colonic motility and secretion in conscious rats. Peptides 2010, 31:1113-1117.
20. Cheung W.W., Mak R.H. Ghrelin in chronic kidney disease. Int. J. Pept. 2010, 2010.
21. Dagli A.F., Aydin S., Karaoglu A., Akpolat N., Ozercan I.H., Ozercan M.R. Ghrelin expression in normal kidney tissue and renal carcinomas. Pathol. Res. Pract. 2009, 205:165-173.
22. De Smet B., Thijs T., Peeters T.L., Depoortere I. Effect of peripheral obestatin on gastric emptying and intestinal contractility in rodents. Neurogastroenterol. Motil. 2007, 19:211-217.
23. Depoortere I., Thijs T., Moechars D., De Smet B., Ver Donck L., Peeters T.L. Effect of peripheral obestatin on food intake and gastric emptying in ghrelin-knockout mice. Br. J. Pharmacol. 2008, 153:1550-1557.
24. Dun S.L., Brailoiu G.C., Brailoiu E., Yang J., Chang J.K., Dun N.J. Distribution and biological activity of obestatin in the rat. J. Endocrinol. 2006, 191:481-489.
25. Egido E.M., Hernandez R., Marco J., Silvestre R.A. Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas. Regul. Pept. 2009, 152:61-66.
26. Fujimiya M, Asakawa A., Ataka K., Kato I., Inui A. Different effects of ghrelin, des-acyl ghrelin and obestatin on gastroduodenal motility in conscious rats. World J. Gastroenterol. 2008, 14:6318-6326.
27. Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol. 2010, 316:129-139.
28. Gao X.Y., Kuang H.Y., Liu X.M., Duan P., Yang Y., Ma Z.B. Circulating ghrelin/obestatin ratio in subjects with Helicobacter pylori infection. Nutrition 2009, 25:506-511.
29. Gao X.Y., Kuang H.Y., Liu X.M., Ma Z.B., Nie H.J., Guo H. Plasma obestatin levels in men with chronic atrophic gastritis. Peptides 2008, 29:1749-1754.
30. Gao X.Y., Kuang H.Y., Liu X.M., Wang X.Y., Pan Y.H., Ma X.X. Decreased obestatin in plasma in metabolically obese, normal-weight men with normal glucose tolerance. Diab. Res. Clin. Pract. 2008, 79:e5-e6.
31. Germain N., Galusca B., Grouselle D., Frere D., Billard S., Epelbaum J., Estour B. Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa. J. Clin. Endocrinol. Metab. 2010, 95:3057-3062.
32. Gourcerol G., Million M., Adelson D.W., Wang Y., Wang L., Rivier J., St-Pierre D.H., Tache Y. Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents. Peptides 2006, 27:2811-2819.
33. Grala T.M., Kay J.K., Walker C.G., Sheahan A.J., Littlejohn M.D., Lucy M.C., Roche J.R. Expression analysis of key somatotropic axis and liporegulatory genes in ghrelin- and obestatin-infused dairy cows. Domest. Anim. Endocrinol. 2010, 39:76-83.
34. Granata R., Baragli A., Settanni F., Scarlatti F., Ghigo E. Unraveling the role of the ghrelin gene peptides in the endocrine pancreas. J. Mol. Endocrinol. 2010, 45:107-118.
35. Granata R., Settanni F., Gallo D., Trovato L., Biancone L., Cantaluppi V., Nano R., Annunziata M., Campiglia P., Arnoletti E., Ghe C., Volante M., Papotti M., Muccioli G., Ghigo E. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes 2008, 57:967-979.
36. Granata R., Volante M., Settanni F., Gauna C., Ghe C., Annunziata M., Deidda B., Gesmundo I., Abribat T., van der Lely A.J., Muccioli G., Ghigo E., Papotti M. Unacylated ghrelin and obestatin increase islet cell mass and prevent diabetes in streptozotocin-treated newborn rats. J. Mol. Endocrinol. 2010, 45:9-17.
37. Green B.D., Irwin N., Flatt P.R. Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides 2007, 28:981-987.
38. Gronberg M., Amini R.M., Stridsberg M., Janson E.T., Saras J. Neuroendocrine markers are expressed in human mammary glands. Regul. Pept. 2010, 160:68-74.
39. Gronberg M., Tsolakis A.V., Magnusson L., Janson E.T., Saras J. Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J. Histochem. Cytochem. 2008, 56:793-801.
40. Guo Z.F., Ren A.J., Zheng X., Qin Y.W., Cheng F., Zhang J., Wu H., Yuan W.J., Zou L. Different responses of circulating ghrelin, obestatin levels to fasting, re-feeding and different food compositions, and their local expressions in rats. Peptides 2008, 29:1247-1254.
41. Guo Z.F., Zheng X., Qin Y.W., Hu J.Q., Chen S.P., Zhang Z. Circulating preprandial ghrelin to obestatin ratio is increased in human obesity. J. Clin. Endocrinol. Metab. 2007, 92:1875-1880.
42. Gurriaran-Rodriguez U., Al-Massadi O., Roca-Rivada A., Crujeiras A.B., Gallego R., Pardo M., Seoane L.M., Pazos Y., Casanueva F.F., Camina J.P. Obestatin as a regulator of adipocyte metabolism and adipogenesis. J. Cell. Mol. Med. 2010.
43. Hassouna R., Zizzari P., Tolle V. The ghrelin/obestatin balance in the physiological and pathological control of growth hormone secretion, body composition and food intake. J. Neuroendocrinol. 2010, 22:793-804.
44. Holst B., Egerod K.L., Schild E., Vickers S.P., Cheetham S., Gerlach L.O., Storjohann L., Stidsen C.E., Jones R., Beck-Sickinger A.G., Schwartz T.W. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 2007, 148:13-20.
45. Iglesias M.J., Salgado A., Pineiro R., Rodino B.K., Otero M.F., Grigorian L., Gallego R., Dieguez C., Gualillo O., Gonzalez-Juanatey J.R., Lago F. Lack of effect of the ghrelin gene-derived peptide obestatin on cardiomyocyte viability and metabolism. J. Endocrinol. Invest. 2007, 30:470-476.
46. Kapica M., Puzio I., Kato I., Kuwahara A., Zabielski R. Role of feed-regulating peptides on pancreatic exocrine secretion. J. Physiol. Pharmacol. 2008, 59(Suppl. 2):145-159.
47. Kapica M., Zabielska M., Puzio I., Jankowska A., Kato I., Kuwahara A., Zabielski R. Obestatin stimulates the secretion of pancreatic juice enzymes through a vagal pathway in anaesthetized rats - preliminary results. J. Physiol. Pharmacol. 2007, 58(Suppl. 3):123-130.
48. Karaoglu A., Aydin S., Dagli A.F., Cummings D.E., Ozercan I.H., Canatan H., Ozkan Y. Expression of obestatin and ghrelin in papillary thyroid carcinoma. Mol. Cell. Biochem. 2009, 323:113-118.
49. Kobelt P., Wisser A.S., Stengel A., Goebel M., Bannert N., Gourcerol G., Inhoff T., Noetzel S., Wiedenmann B., Klapp B.F., Tache Y., Monnikes H. Peripheral obestatin has no effect on feeding behavior and brain Fos expression in rodents. Peptides 2008, 29:1018-1027.
50. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
51. Lago R., Gomez R., Dieguez C., Gomez-Reino J.J., Lago F., Gualillo O. Unlike ghrelin, obestatin does not exert any relevant activity in chondrocytes. Ann. Rheum. Dis. 2007, 66:1399-1400.
52. Lauwers E., Landuyt B., Arckens L., Schoofs L., Luyten W. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem. Biophys. Res. Commun. 2006, 351:21-25.
53. Li Z.F., Guo Z.F., Cao J., Hu J.Q., Zhao X.X., Xu R.L., Huang X.M., Qin Y.W., Zheng X. Plasma ghrelin and obestatin levels are increased in spontaneously hypertensive rats. Peptides 2010, 31:297-300.
54. Li Z.F., Guo Z.F., Yang S.G., Zheng X., Cao J., Qin Y.W. Circulating ghrelin and ghrelin to obestatin ratio are low in patients with untreated mild-to-moderate hypertension. Regul. Pept. 2010.
55. Li Z.F., Song S.W., Qin Y.W., Zhang J.L., Zhao X.X., Zhang B.L., Ren A.J., Guo Z.F., Zheng X. Bolus intravenous injection of obestatin does not change blood pressure level of spontaneously hypertensive rat. Peptides 2009, 30:1928-1930.
56. Lippl F., Erdmann J., Lichter N., Tholl S., Wagenpfeil S., Adam O., Schusdziarra V. Relation of plasma obestatin levels to bmi, gender, age and insulin. Horm. Metab. Res. 2008, 40:806-812.
57. Mafra D., Guebre-Egziabher F., Cleaud C., Arkouche W., Mialon A., Drai J., Fouque D. Obestatin and ghrelin interplay in hemodialysis patients. Nutrition 2009.
58. Mafra D., Guebre-Egziabher F., Fouque D. Endocrine role of stomach in appetite regulation in chronic kidney disease: about ghrelin and obestatin. J. Ren. Nutr. 2010, 20:68-73.
59. Malendowicz W., Ziolkowska A., Szyszka M., Kwias Z. Elevated blood active ghrelin and unaltered total ghrelin and obestatin concentrations in prostate carcinoma. Urol. Int. 2009, 83:471-475.
60. Markowska A., Ziolkowska A., Jaszczynska-Nowinka K., Madry R., Malendowicz L.K. Elevated blood plasma concentrations of active ghrelin and obestatin in benign ovarian neoplasms and ovarian cancers. Eur. J. Gynaecol. Oncol. 2009, 30:518-522.
61. Markowska A., Ziolkowska A., Nowinka K., Malendowicz L.K. Elevated blood active ghrelin and normal total ghrelin and obestatin concentrations in uterine leiomyoma. Eur. J. Gynaecol. Oncol. 2009, 30:281-284.
62. Meszarosova M., Sirotkin A.V., Grossmann R., Darlak K., Valenzuela F. The effect of obestatin on porcine ovarian granulosa cells. Anim. Reprod. Sci. 2008, 108:196-207.
63. Mondal M.S., Toshinai K., Ueno H., Koshinaka K., Nakazato M. Characterization of obestatin in rat and human stomach and plasma, and its lack of acute effect on feeding behavior in rodents. J. Endocrinol. 2008, 198:339-346.
64. Monteleone P., Serritella C., Martiadis V., Scognamiglio P., Maj M. Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa. J. Clin. Endocrinol. Metab. 2008, 93:4418-4421.
65. Morash M.G., Gagnon J., Nelson S., Anini Y. Tissue distribution and effects of fasting and obesity on the ghrelin axis in mice. Regul. Pept. 2010, 163:62-73.
66. Mori K., Yoshimoto A., Takaya K., Hosoda K., Ariyasu H., Yahata K., Mukoyama M., Sugawara A., Hosoda H., Kojima M., Kangawa K., Nakao K. Kidney produces a novel acylated peptide, ghrelin. FEBS Lett. 2000, 486:213-216.
67. Nagaraj S., Peddha M.S., Manjappara U.V. Fragments of obestatin as modulators of feed intake, circulating lipids, and stored fat. Biochem. Biophys. Res. Commun. 2008, 366:731-737.
68. Nagaraj S., Peddha M.S., Manjappara U.V. Fragment analogs as better mimics of obestatin. Regul. Pept. 2009, 158:143-148.
69. Nogueiras R., Pfluger P., Tovar S., Arnold M., Mitchell S., Morris A., Perez-Tilve D., Vazquez M.J., Wiedmer P., Castaneda T.R., DiMarchi R., Tschop M., Schurmann A., Joost H.G., Williams L.M., Langhans W., Dieguez C. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology 2007, 148:21-26.
70. Ozbay Y., Aydin S., Dagli A.F., Akbulut M., Agli N.L., Kilic N., Rahman A., Sahin I., Polat V., Ozercan H.I., Arslan N., Sensoy D. Obestatin is present in saliva: alterations in obestatin and ghrelin levels of saliva and serum in ischemic heart disease. Bmb Rep. 2008, 41:55-61.
71. Pan W., Tu H., Kastin A.J. Differential BBB interactions of three ingestive peptides: obestatin, ghrelin, and adiponectin. Peptides 2006, 27:911-916.
72. Pazos Y., Alvarez C.J., Camina J.P., Al-Massadi O., Seoane L.M., Casanueva F.F. Role of obestatin on growth hormone secretion: an in vitro approach. Biochem. Biophys. Res. Commun. 2009, 390:1377-1381.
73. Pazos Y., Alvarez C.J., Camina J.P., Casanueva F.F. Stimulation of extracellular signal-regulated kinases and proliferation in the human gastric cancer cells KATO-III by obestatin. Growth Factors 2007, 25:373-381.
74. Pemberton C.J., Richards A.M. Biochemistry of ghrelin precursor peptides. Vitam. Horm. 2008, 77:13-30.
75. Qader S.S., Hakanson R., Rehfeld J.F., Lundquist I., Salehi A. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas. Regul. Pept. 2008, 146:230-237.
76. Ren A.J., Guo Z.F., Wang Y.K., Wang L.G., Wang W.Z., Lin L., Zheng X., Yuan W.J. Inhibitory effect of obestatin on glucose-induced insulin secretion in rats. Biochem. Biophys. Res. Commun. 2008, 369:969-972.
77. Ren A.J., He Q., Shi J.S., Guo Z.F., Zheng X., Lin L., Wang Y.K., Xia S.Y., Sun L.L., Du X., Sun Y., Zhang L.M., Yuan W.J. Association of obestatin with blood pressure in the third trimesters of pregnancy. Peptides 2009, 30:1742-1745.
78. Rucinski M., Trejter M., Ziolkowska A., Tyczewska M., Malendowicz L.K. Ghrelin and obestatin inhibit enucleation-induced adrenocortical proliferation in the rat. Int. J. Mol. Med. 2010, 25:793-800.
79. Samson W.K., White M.M., Price C., Ferguson A.V. Obestatin acts in brain to inhibit thirst. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292:R637-R643.
80. Samson W.K., Yosten G.L., Chang J.K., Ferguson A.V., White M.M. Obestatin inhibits vasopressin secretion: evidence for a physiological action in the control of fluid homeostasis. J. Endocrinol. 2008, 196:559-564.
81. Sazdova I., Ilieva B., Minkov I., Schubert R., Gagov H. Obestatin as contractile mediator of excised frog heart. Cent. Eur. J. Biol. 2009, 4:327-334.
82. Sedlackova D., Kopeckova J., Papezova H., Vybiral S., Kvasnickova H., Hill M., Nedvidkova J. Changes of plasma obestatin, ghrelin and NPY in anorexia and bulimia nervosa patients before and after a high-carbohydrate breakfast. Physiol. Res. 2010.
83. Seim I., Amorim L., Walpole C., Carter S., Chopin L.K., Herington A.C. Ghrelin gene-related peptides: multifunctional endocrine/autocrine modulators in health and disease. Clin. Exp. Pharmacol. Physiol. 2010, 37:125-131.
84. Seim I., Collet C., Herington A.C., Chopin L.K. Revised genomic structure of the human ghrelin gene and identification of novel exons, alternative splice variants and natural antisense transcripts. BMC Genomics 2007, 8:298.
85. Sibilia V., Bresciani E., Lattuada N., Rapetti D., Locatelli V., De Luca V., Dona F., Netti C., Torsello A., Guidobono F. Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. J. Endocrinol. Invest. 2006, 29:RC31-RC34.
86. Szentirmai E., Kapas L., Sun Y., Smith R.G., Krueger J.M. The preproghrelin gene is required for the normal integration of thermoregulation and sleep in mice. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:14069-14074.
87. Szentirmai E., Krueger J.M. Obestatin alters sleep in rats. Neurosci. Lett. 2006, 404:222-226.
88. Tremblay F., Perreault M., Klaman L.D., Tobin J.F., Smith E., Gimeno R.E. Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39. Endocrinology 2007, 148:501-506.
89. Tsolakis A.V., Grimelius L., Stridsberg M., Falkmer S.E., Waldum H.L., Saras J., Janson E.T. Obestatin/ghrelin cells in normal mucosa and endocrine tumours of the stomach. Eur. J. Endocrinol. 2009, 160:941-949.
90. Unniappan S., Speck M., Kieffer T.J. Metabolic effects of chronic obestatin infusion in rats. Peptides 2008, 29:1354-1361.
91. Van Dijck A., Van Dam D., Vergote V., De Spiegeleer B., Luyten W., Schoofs L., De Deyn P.P. Central administration of obestatin fails to show inhibitory effects on food and water intake in mice. Regul. Pept. 2009, 156:77-82.
92. Vergote V., Van Dorpe S., Peremans K., Burvenich C., De Spiegeleer B. In vitro metabolic stability of obestatin: kinetics and identification of cleavage products. Peptides 2008, 29:1740-1748.
93. Volante M., Rosas R., Ceppi P., Rapa I., Cassoni P., Wiedenmann B., Settanni F., Granata R., Papotti M. Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth. J. Pathol. 2009, 218:458-466.
94. Walia P., Asadi A., Kieffer T.J., Johnson J.D., Chanoine J.P. Ontogeny of ghrelin, obestatin, preproghrelin, and prohormone convertases in rat pancreas and stomach. Pediatr. Res. 2009, 65:39-44.
95. Xin X., Ren A.J., Zheng X., Qin Y.W., Zhao X.X., Yuan W.J., Guo Z.F. Disturbance of circulating ghrelin and obestatin in chronic heart failure patients especially in those with cachexia. Peptides 2009, 30:2281-2285.
96. Yamamoto D., Ikeshita N., Daito R., Herningtyas E.H., Toda K., Takahashi K., Iida K., Takahashi Y., Kaji H., Chihara K., Okimura Y. Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats. Regul. Pept. 2007, 138:141-144.
97. Yasuda S., Miyazaki T., Munechika K., Yamashita M., Ikeda Y., Kamizono A. Isolation of Zn2+ as an endogenous agonist of GPR39 from fetal bovine serum. J. Recept. Signal Transduct. Res. 2007, 27:235-246.
98. Zhang J.V., Jahr H., Luo C.W., Klein C., Van Kolen K., Ver Donck L., De A., Baart E., Li J., Moechars D., Hsueh A.J. Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39. Mol. Endocrinol. 2008, 22:1464-1475.
99. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., Hsueh A.J. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005, 310:996-999.
100. Zhang N., Yuan C., Li Z., Li J., Li X., Li C., Li R., Wang S.R. Meta-analysis of the relationship between obestatin and ghrelin levels and the ghrelin/obestatin ratio with respect to obesity. Am. J. Med. Sci. 2011, 341:48-55.
101. Zhang W., Chai B., Li J.Y., Wang H., Mulholland M.W. Effect of des-acyl ghrelin on adiposity and glucose metabolism. Endocrinology 2008, 149:4710-4716.
102. Zhao C.M., Furnes M.W., Stenstrom B., Kulseng B., Chen D. Characterization of obestatin- and ghrelin-producing cells in the gastrointestinal tract and pancreas of rats: an immunohistochemical and electron-microscopic study. Cell Tissue Res. 2008, 331:575-587.
103. Zizzari P., Longchamps R., Epelbaum J., Bluet-Pajot M.T. Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology 2007, 148:1648-1653.